(1)
THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF VARIOUS STAGES OF DIABETIC RETINOPATHY (LITERATURE REVIEW). Wor.Bul.Pub.Helt. 2022, 10, 81-84.